Close
ACHEMA MIDDLE EAST 2026

Data Intelligence Is The Key To Turning Lab Outcomes Better

With the advancement when it comes to automation and new drug modalities, modern labs happen to generate more data than ever; however, turning data...

AI Can Indeed Revolutionize The Pharma Compound Synthesis

Researchers from the University of Cambridge, UK, along with a leading global pharmaceutical company, have gone on to develop an AI-powered platform that can...

The Digital Transition Pharma Landscape Is Going Through

The enlarged significance of digital innovation has prominently transformed how pharma goes on to function. A worldwide surge in traffic when it comes to...

Role of GenAI In Speeding Up Pharmaceuticals To Market

The fact is that Generative AI- GenAI is revolutionizing the life sciences sector, and one is just at the surface of it. It is worth...

The State of GenAI In The Pharmaceutical Industry Today

According to a recent survey from the Pistoia Alliance, AI and machine learning- ML are going to be the top technology investments when it...

Synergising SaaS & Cloud Comm With AI For Better Pharma

The pharmaceutical backdrop is going through a remarkable shift pushed by disruptive technologies: Software as a Service- SaaS, Infrastructure as a Service- IaaS as...

AI In Pharma: Possibility European Regulators Look To Propel

The European Medicines Agency- EMA and the Heads of Medicines Agencies- HMAs have gone on to publish a plan that helps to set out...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...